Concepedia

Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patients

Romain Coriat, Olivier Mir, Sandra Camps, Stanislas Ropert, Bertrand Billemont, Mahaut Leconte, Fréderique Larousserie, Philippe Anract, Jérôme Alexandre, François Goldwasser

Cancer Chemotherapy and Pharmacology · 2009 · 17 citations · 20 references

DOI

Concepts

References

20

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

Paul Lorigan, Jaap Verweij, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2007 · 256 citations · Full text

, , +15

Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas

Vivien Bramwell, Henning T. Mouridsen, Armando Santoro et al. · European Journal of Cancer and Clinical Oncology · 1987 · 243 citations

, , +8

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

K H Antman, Louise Ryan, Alby Elias et al. · Journal of Clinical Oncology · 1989 · 239 citations

, , +15

High-dose ifosfamide with mesna uroprotection: a phase I study.

Anthony Elias, Joseph P. Eder, Colin B. Begg et al. · Journal of Clinical Oncology · 1990 · 145 citations

, , +13

Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy

J. Alexandre, M. Gross-Goupil, Bruno Falissard et al. · Annals of Oncology · 2002 · 133 citations

, , +17